A 32-year-old farmer is brought to the emergency department by his wife. The patient was reportedly anxious, sweaty, and complaining of a headache and chest tightness before losing consciousness on route to the hospital. Which of the following is mechanistically responsible for this patient's symptoms?

Irreversible inhibition of acetylcholinesterase

Reversible inhibition of acetylcholinesterase

Competitive inhibition of acetylcholine at post-junctional effector sites

Binding of acetylcholine agonists to post-junctional receptors

Inhibition of presynaptic exocytosis of acetylcholine vesicles

A 63-year-old man comes to the physician for blurry vision and increased difficulty walking over the past month. He feels very fatigued after watering his garden but feels better after taking a nap. He has not had any recent illness. He has smoked one pack of cigarettes daily for 35 years. Examination shows drooping of the upper eyelids bilaterally and diminished motor strength in the upper extremities. Sensation to light touch and deep tendon reflexes are intact. An x-ray of the chest shows low lung volumes bilaterally. A drug with which of the following mechanisms of action is most appropriate for this patient?

Inhibition of acetylcholinesterase

Regeneration of acetylcholinesterase

Inhibition of muscarinic ACh receptor

Stimulation of β2 adrenergic receptors

A researcher is studying receptors that respond to epinephrine in the body and discovers a particular subset that is expressed in presynaptic adrenergic nerve terminals. She discovers that upon activation, these receptors will lead to decreased sympathetic nervous system activity. She then studies the intracellular second messenger changes that occur when this receptor is activated. She records these changes and begins searching for analogous receptor pathways. Which of the following receptors would cause the most similar set of intracellular second messenger changes?

Dopamine receptors in the brain

Muscarinic cholinoreceptors in the gastrointestinal tract

Growth hormone receptors in the musculoskeletal system

Vasopressin receptors in the kidney

Aldosterone receptors in the kidney

Cholinergic agonists (direct and indirect) for USMLE Step 1: High-Yield Pharmacology Lessons

Cholinergic Receptors - The Body's Light Switches

Two main types: Muscarinic (G-protein coupled) & Nicotinic (ligand-gated ion channels).
Muscarinic (M) Receptors:
- M1 (Gq): CNS, enteric nervous system.
- M2 (Gi): Heart (↓ heart rate, ↓ contractility).
- M3 (Gq): Glands (↑ secretion), smooth muscle (contraction), endothelium (↑NO → vasodilation).
- 📌 Mnemonic (G-protein type): "QIQ" for M1, M2, M3.
Nicotinic (N) Receptors:
- Nn (neuronal): Autonomic ganglia, adrenal medulla.
- Nm (muscle): Neuromuscular junction → skeletal muscle contraction.

Cholinergic Synapse: Receptors, Synthesis, and Degradation

⭐ High-Yield: Atropine is a muscarinic antagonist. Low doses preferentially block presynaptic M1 receptors that inhibit ACh release, leading to a paradoxical transient bradycardia before the expected tachycardia from postsynaptic M2 blockade dominates.

Direct Agonists - The Master Keys

Directly bind & activate cholinergic (muscarinic/nicotinic) receptors, mimicking acetylcholine (ACh).
Types:
- Choline Esters: Bethanechol, Carbachol, Methacholine.
- Alkaloids: Pilocarpine (tertiary amine, can cross CNS).

Drug	Receptor Target (M/N)	Key Clinical Use
Bethanechol	M > N	Post-op ileus, urinary retention
Carbachol	M, N	Glaucoma, miosis induction
Pilocarpine	M > N	Sjögren's (dry mouth), glaucoma
Methacholine	M > N	Bronchial challenge test for asthma

Cholinergic synapse: receptors, agonists, and antagonists

Indirect Agonists - The Volume Knobs

These drugs boost acetylcholine (ACh) concentration in the synaptic cleft by inhibiting acetylcholinesterase (AChE), the enzyme responsible for ACh breakdown. This effectively "turns up the volume" on existing cholinergic signals.

Acetylcholine synthesis, release, and breakdown

Reversible Inhibitors
- -stigmines: Neostigmine, Pyridostigmine (Myasthenia Gravis), Physostigmine (Atropine OD).
- Alzheimer's Disease: Donepezil, Rivastigmine, Galantamine (CNS-acting).
Irreversible Inhibitors (Organophosphates)
- Toxic agents (e.g., parathion, sarin gas).
- Cause cholinergic crisis (overstimulation).
- 📌 DUMBBELSS: Diarrhea, Urination, Miosis, Bronchospasm, Bradycardia, Emesis, Lacrimation, Salivation, Sweating.

⭐ Pralidoxime (2-PAM) regenerates AChE after organophosphate poisoning but must be given before the enzyme-inhibitor complex "ages." It does not cross the BBB and primarily treats nicotinic (e.g., muscle weakness) effects, while atropine manages muscarinic symptoms.

Cholinergic Crisis - DUMBBELSS Overload

Results from excess acetylcholine (ACh), typically due to organophosphate poisoning which irreversibly inhibits acetylcholinesterase (AChE).
📌 DUMBBELSS Mnemonic for muscarinic effects:
- Diaphoresis / Diarrhea
- Urination
- Miosis (pinpoint pupils)
- Bronchospasm / Bradycardia
- Emesis
- Lacrimation
- Salivation / Sweating

⭐ Pralidoxime regenerates AChE to reverse muscle paralysis but does not cross the BBB; Atropine is required to reverse central and peripheral muscarinic symptoms.

High-Yield Points - ⚡ Biggest Takeaways

Direct agonists like Bethanechol treat non-obstructive urinary retention, while Pilocarpine manages glaucoma and Sjögren's syndrome.

Indirect agonists (-stigmines) are mainstays for Myasthenia Gravis; Donepezil is used for Alzheimer's disease.

Organophosphate poisoning causes a cholinergic crisis (DUMBBELSS), a classic toxidrome.

The antidote for organophosphate toxicity is Atropine (muscarinic antagonist) plus Pralidoxime (regenerates AChE).

Edrophonium is a short-acting agent historically used in the Tensilon test to diagnose Myasthenia Gravis.

Continue reading on Oncourse

CONTINUE READING — FREE

or get the app

App Store|Google Play